U.S. markets closed

Personalis, Inc. (PSNL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.80-0.50 (-2.15%)
At close: 4:00PM EDT

Personalis, Inc.

1330 O’Brien Drive
Menlo Park, CA 94025
United States
650 752 1300
http://www.personalis.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full Time Employees234

Key Executives

NameTitlePayExercisedYear Born
Mr. John Stephen WestCo-Founder, CEO, Pres & Director1.03MN/A1957
Mr. Aaron L. TachibanaChief Financial Officer603.5kN/A1961
Dr. Richard Chen M.S., M.D., MSChief Scientific Officer638.5kN/A1971
Prof. Russ B. AltmanCo-Founder and Member of Clinical & Scientific Advisory BoardN/AN/AN/A
Dr. Euan A. Ashley M.D., Ph.D., FRCP, DPHILCo-Founder and Member of Clinical & Scientific Advisory BoardN/AN/AN/A
Dr. Atul ButteCo-Founder and Member of Clinical & Scientific Advisory BoardN/AN/AN/A
Dr. Michael SnyderCo-Founder and Member of Clinical & Scientific Advisory BoardN/AN/AN/A
Ms. Carol J. TillisVP of Fin. & Admin.N/AN/AN/A
Mr. Stephen M. Moore J.D.Gen. CounselN/AN/AN/A
Mr. Michael J. FitzpatrickVP of Worldwide SalesN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies. It offers NeXT Platform, which provides data for cancer therapy development, personalized therapies, therapy selection, and diagnostics. The company also provides a complementary liquid biopsy assay that analyzes various human genes versus. It serves biopharmaceutical customers, universities and non-profits, diagnostics companies, and government entities. The company has partnership with Berry Genomics; Natera, Inc.; and MapKure, LLC. Personalis, Inc. was founded in 2011 and is headquartered in Menlo Park, California.

Corporate Governance

Personalis, Inc.’s ISS Governance QualityScore as of June 1, 2021 is 8. The pillar scores are Audit: 2; Board: 9; Shareholder Rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.